BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Scarfe L, Menshikh A, Newton E, Zhu Y, Delgado R, Finney C, de Caestecker MP. Long-term outcomes in mouse models of ischemia-reperfusion-induced acute kidney injury. Am J Physiol Renal Physiol 2019;317:F1068-80. [PMID: 31411074 DOI: 10.1152/ajprenal.00305.2019] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Harwood R, Bridge J, Ressel L, Scarfe L, Sharkey J, Czanner G, Kalra PA, Odudu A, Kenny S, Wilm B, Murray P. Murine models of renal ischemia reperfusion injury: An opportunity for refinement using noninvasive monitoring methods. Physiol Rep 2022;10:e15211. [PMID: 35266337 DOI: 10.14814/phy2.15211] [Reference Citation Analysis]
2 Najar-Acosta LJ, Robles-Murillo AK, León-Moreno LC, Desentis-Desentis MF, García-Espinoza JA, Barba-Gutiérrez JP, Romero-Gómez AG, Del Toro-Arreola A, Daneri-Navarro A, Topete-Camacho A, Franco-Topete RA, Sánchez-Zubieta FA, Zepeda-Moreno A, Rivas-Carrillo JD. Establishment of Murine Model of Kidney Failure Induced by Severe Ischemia-Reperfusion Injury Useful to Evaluate Transplantation and Regenerative Therapies. Transplant Proc 2020;52:1202-5. [PMID: 32164959 DOI: 10.1016/j.transproceed.2020.02.014] [Reference Citation Analysis]
3 Chen YT, Jhao PY, Hung CT, Wu YF, Lin SJ, Chiang WC, Lin SL, Yang KC. Endoplasmic reticulum protein TXNDC5 promotes renal fibrosis by enforcing TGF-β signaling in kidney fibroblasts. J Clin Invest 2021;131:143645. [PMID: 33465051 DOI: 10.1172/JCI143645] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
4 Wang F, Otsuka T, Adelnia F, Takahashi K, Delgado R, Harkins KD, Zu Z, de Caestecker MP, Harris RC, Gore JC, Takahashi T. Multiparametric magnetic resonance imaging in diagnosis of long-term renal atrophy and fibrosis after ischemia reperfusion induced acute kidney injury in mice. NMR Biomed 2022;:e4786. [PMID: 35704387 DOI: 10.1002/nbm.4786] [Reference Citation Analysis]
5 Hukriede NA, Soranno DE, Sander V, Perreau T, Starr MC, Yuen PST, Siskind LJ, Hutchens MP, Davidson AJ, Burmeister DM, Faubel S, de Caestecker MP. Experimental models of acute kidney injury for translational research. Nat Rev Nephrol 2022. [PMID: 35173348 DOI: 10.1038/s41581-022-00539-2] [Reference Citation Analysis]
6 Long K, Vaughn Z, McDaniels MD, Joyasawal S, Przepiorski A, Parasky E, Sander V, Close D, Johnston PA, Davidson AJ, de Caestecker M, Hukriede NA, Huryn DM. Validation of HDAC8 Inhibitors as Drug Discovery Starting Points to Treat Acute Kidney Injury. ACS Pharmacol Transl Sci 2022;5:207-15. [PMID: 35434532 DOI: 10.1021/acsptsci.1c00243] [Reference Citation Analysis]
7 Basile DP. The case for capillary rarefaction in the AKI to CKD progression: insights from multiple injury models. American Journal of Physiology-Renal Physiology 2019;317:F1253-4. [DOI: 10.1152/ajprenal.00468.2019] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
8 Menshikh A, Scarfe L, Delgado R, Finney C, Zhu Y, Yang H, de Caestecker MP. Capillary rarefaction is more closely associated with CKD progression after cisplatin, rhabdomyolysis, and ischemia-reperfusion-induced AKI than renal fibrosis. Am J Physiol Renal Physiol 2019;317:F1383-97. [PMID: 31509009 DOI: 10.1152/ajprenal.00366.2019] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 3.7] [Reference Citation Analysis]